Australia's most trusted
source of pharma news
Friday, 19 December 2025
Posted 18 December 2025 AM
A further $1.8465 billion is expected to be added to reimbursements made through the R/PBS over the next four fiscal years due to recent government listings to the Scheme.
The costings are revealed in the Mid-Year Economic and Fiscal Outlook (MYFEO) 2025–26 released this week. The vast majority of the extra spending will be through the PBS, with a fraction going through the RPBS and just over a million going through Services Australia.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.